12/23
04:16 pm
tmdx
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/23
04:05 pm
tmdx
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
12/17
08:15 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $75.00 price target on the stock, down previously from $116.00.
Medium
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $75.00 price target on the stock, down previously from $116.00.
12/12
04:05 pm
tmdx
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12/11
08:21 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
12/11
08:21 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Robert W. Baird from $150.00 to $120.00. They now have an "outperform" rating on the stock.
Low
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Robert W. Baird from $150.00 to $120.00. They now have an "outperform" rating on the stock.
12/11
08:21 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Piper Sandler from $110.00 to $90.00. They now have an "overweight" rating on the stock.
Low
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Piper Sandler from $110.00 to $90.00. They now have an "overweight" rating on the stock.
12/8
04:46 am
tmdx
Down Over 60%, Is TransMedics Stock a Buy on the Dip? [Yahoo! Finance]
Low
Report
Down Over 60%, Is TransMedics Stock a Buy on the Dip? [Yahoo! Finance]
12/3
09:07 pm
tmdx
TMDX INVESTIGATION: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Low
Report
TMDX INVESTIGATION: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
12/3
12:47 pm
tmdx
Why TransMedics Stock Plummeted Today [Yahoo! Finance]
Low
Report
Why TransMedics Stock Plummeted Today [Yahoo! Finance]
12/3
10:15 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $125.00 price target on the stock.
Medium
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $125.00 price target on the stock.
12/3
09:03 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
12/2
04:57 pm
tmdx
TransMedics appoints Gerardo Hernandez as CFO [Seeking Alpha]
Medium
Report
TransMedics appoints Gerardo Hernandez as CFO [Seeking Alpha]
12/2
04:19 pm
tmdx
TransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook [Yahoo! Finance]
Medium
Report
TransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook [Yahoo! Finance]
12/2
04:05 pm
tmdx
TransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook
High
Report
TransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook
11/27
01:17 pm
tmdx
Is TMDX Stock a Buy, Sell or Hold at a P/S Multiple of 5.02X? [Yahoo! Finance]
Medium
Report
Is TMDX Stock a Buy, Sell or Hold at a P/S Multiple of 5.02X? [Yahoo! Finance]
11/26
04:10 pm
tmdx
TransMedics to Host Investor & Analyst Day on December 10, 2024 [Yahoo! Finance]
Medium
Report
TransMedics to Host Investor & Analyst Day on December 10, 2024 [Yahoo! Finance]
11/26
04:05 pm
tmdx
TransMedics to Host Investor & Analyst Day on December 10, 2024
Medium
Report
TransMedics to Host Investor & Analyst Day on December 10, 2024
11/26
06:50 am
tmdx
TransMedics Group's (NASDAQ:TMDX) investors will be pleased with their massive 349% return over the last five years [Yahoo! Finance]
Medium
Report
TransMedics Group's (NASDAQ:TMDX) investors will be pleased with their massive 349% return over the last five years [Yahoo! Finance]
11/23
04:30 am
tmdx
2 Hypergrowth Stocks That Are Screaming Buys in November [Yahoo! Finance]
Medium
Report
2 Hypergrowth Stocks That Are Screaming Buys in November [Yahoo! Finance]
11/22
08:13 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. They now have a $109.00 price target on the stock.
Low
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. They now have a $109.00 price target on the stock.
11/22
05:07 am
tmdx
Jim Cramer on TransMedics Group, Inc. (TMDX): ‘I Don't Know How You Can Really Make A Lot Of Money In That Business, Frankly' [Yahoo! Finance]
Low
Report
Jim Cramer on TransMedics Group, Inc. (TMDX): ‘I Don't Know How You Can Really Make A Lot Of Money In That Business, Frankly' [Yahoo! Finance]
11/20
01:16 pm
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Piper Sandler from $180.00 to $110.00. They now have an "overweight" rating on the stock.
Low
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Piper Sandler from $180.00 to $110.00. They now have an "overweight" rating on the stock.
11/20
09:31 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $109.00 to $104.00. They now have a "buy" rating on the stock.
Medium
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $109.00 to $104.00. They now have a "buy" rating on the stock.
11/19
07:42 pm
tmdx
Lightning Round: Coterra Energy is far superior to Devon Energy [CNBC]
Medium
Report
Lightning Round: Coterra Energy is far superior to Devon Energy [CNBC]